Crossmark

Letter to the Editor - Reply to “Advancing AI Ethics Frameworks in Drug Development: Global Applicability, Practical Challenges, and Dynamic Governance”

Crossref DOI link: https://doi.org/10.1007/s43441-025-00813-y

Published Online: 2025-05-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ménard, Timothé https://orcid.org/0000-0003-4545-6944
Bramstedt, Katrina A. https://orcid.org/0000-0001-5446-0123
License Information

Text and Data Mining valid from 2025-05-26

Version of Record valid from 2025-05-26
More Information

Article History

Received: 7 May 2025

Accepted: 22 May 2025

First Online: 26 May 2025

Declarations

:

: Not applicable.

: Not applicable.

: At the time this article was written, Timothé Ménard and Katrina Bramstedt were employed by Roche and owned F. Hoffmann-La Roche Ag stock.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below